Simpson et al.'s study, chronic active MS lesions were found to be associated with CCR2, CCR3, and CCR5, particularly in foamy macrophages and activated microglia, with CCR2 and CCR5 also being prevalent in infiltrating lymphocytes (54, 55). This evidence concerns the gene CCR5 and myeloid sarcoma.